Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Microbiology Spectrum|April 26, 2023
Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5Gabriel Diem, Michael Jäger, Stefanie Dichtl, et al.
The Journal of Infectious Diseases|March 4, 2023
Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 VariantsMichael Jäger, Gabriel Diem, Sabina Sahanic, et al.
Respiratory Research|February 28, 2024
P80 natural essence spray and lozenges provide respiratory protection against Influenza A, B, and SARS-CoV-2Viktoria Zaderer, Gabriel Diem, Wilfried Posch, et al.
Frontiers in Immunology|July 14, 2022
Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 VaccineesMichael Jäger, Sissy Therese Sonnleitner, Stefanie Dichtl, et al.
The Journal of Infectious Diseases|September 10, 2025
The Role of Enoxaparin in Influenza Virus Infections and Its Therapeutic ImplicationsMarta Bermejo-Jambrina, Viktoria Zaderer, Julia Eder, et al.
Mbio|October 12, 2021
Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon ResponsesWilfried Posch, Marta Bermejo-Jambrina, Marion Steger, et al.
Microbiology Spectrum|August 8, 2023
Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concernGabriel Diem, Stefanie Dichtl, Viktoria Zaderer, et al.
Antiviral Research|March 25, 2023
Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammationStefanie Dichtl, Gabriel Diem, Michael Jäger, et al.
Frontiers in Immunology|July 1, 2021
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 PatientsEliott Lafon, Gabriel Diem, Christina Witting, et al.
Frontiers in Immunology|July 31, 2023
Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2Renate Pichler, Gabriel Diem, Hubert Hackl, et al.
Pageof 2